Jing Deng

Yanbian University — China

Medicine · Health Sciences

10h-index801citations28works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(4), Oral microbiology and periodontitis research(3), Immune Cell Function and Interaction(3), Colorectal Cancer Treatments and Studies(3), Cancer Treatment and Pharmacology(3)

Publications28 total

Design and Implementation of Intelligent Medical Spray Sterilization Robot Based on ROS and YOLOv8
2025
CXCL16 knockout inhibit asthma airway inflammation by suppressing H2-DM molecular mediated antigen presentation
Cell Death Discovery·2025· 3 citedOpen Access
Peracetic acid activation by chitosan-derived nitrogen-doped carbon spheres loaded with zero-valent copper for efficient sulfamethazine degradation in groundwater
Separation and Purification Technology·2024· 9 cited
14 (PB002): Discovery of NKT3964: a first-in-class, highly potent and selective, orally bioavailable CDK2 PROTAC degrader for cancer therapy
European Journal of Cancer·2024· 3 cited
Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics
Bioactive Materials·2022· 36 citedOpen Access
Biomaterial-based encapsulated probiotics for biomedical applications: Current status and future perspectives
Materials & Design·2021· 76 citedOpen Access
Fucoidan as a marine-origin prebiotic modulates the growth and antibacterial ability of Lactobacillus rhamnosus
International Journal of Biological Macromolecules·2021· 82 cited
A biodegradable antibacterial alginate/carboxymethyl chitosan/Kangfuxin sponges for promoting blood coagulation and full-thickness wound healing
International Journal of Biological Macromolecules·2020· 173 cited
Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
Frontiers in Oncology·2020· 55 citedOpen Access
MMP9 protects against LPS-induced inflammation in osteoblasts
Innate Immunity·2019· 88 citedOpen Access
Novel Aspects of Insulin-like Growth Factor 1/insulin Network in Chronic Inflammatory Airway Disease
Current Medicinal Chemistry·2019· 5 cited
Osteochondral repair using scaffolds with gradient pore sizes constructed with silk fibroin, chitosan, and nano-hydroxyapatite
SHILAP Revista de lepidopterología·2019· 2 citedOpen Access
Clinical Experience on Treatment of Advanced Lung Adenocarcinoma With Unknown EGFR Gene Status From a Tertiary Care Center in China
CHEST Journal·2016
Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China
BMC Infectious Diseases·2014· 28 citedOpen Access
Sequential treatment of icotinib after first-line pemetrexed in advanced lung adenocarcinoma with unknown EGFR gene status.
PubMed·2014· 8 citedOpen Access
A phase II study of biweekly paclitaxel and S-1 (SPA) as first-line combination therapy in patients with metastatic or locally advanced gastric cancer.
Journal of Clinical Oncology·2014
Randomized phase III study of recombinant human Apo-2 ligand (Apo-2 Ligand) plus vinorelbine/cisplatin (NP) verus placebo plus NP in patients with stage IIIB/IV non-small cell lung cancer (NSCLC): A single center report.
Journal of Clinical Oncology·2014
Evaluation of the Quality of Life and Economic Burden with Granulocyte-Colony Stimulating Factor in Chinese Breast Cancer Patients Receiving Docetaxel, Epirubicin and Cyclophosphamide
Annals of Oncology·2012· 1 cited
SU‐D‐BRB‐05: Small Animal Lung Compliance Imaging: Assessment System for Tissue Sensitivity to Radiation Induced Lung Injury
Medical Physics·2012· 1 cited
Biocompatibility of a chitosan-based injectable thermosensitive hydrogel and its effects on dog periodontal tissue regeneration
Carbohydrate Polymers·2010· 91 cited
page 1 of 2Next →

Frequent Co-authors

Yulong Zheng(5), Qihui Zhou(4), Nong Xu(4), Peng Zhao(3), Jiong Qian(3), Yanjing Ji(2), Qiu Xia Ji(2), Yanli Zhu(2), Xiao Cheng(2), Haiping Jiang(2), Chenyu Mao(2), Shusen Zheng(2), Weijia Fang(2), G. Shi(2), Sui Huang(2), Peng Shen(2), Yun He(1), Wenwen Zhao(1), Zuoxiang Dong(1), Min Li(1)